Status:
COMPLETED
Bioabsorbable Versus Durable Polymer Drug Eluting Stent (DES): a Meta-analysis
Lead Sponsor:
Azienda Ospedaliero Universitaria Maggiore della Carita
Conditions:
Restenosis
Myocardial Infarction
Eligibility:
All Genders
18-90 years
Brief Summary
Evidence supporting use of bioabsorbable polymer drug eluting stents (BP-DES) is uncertain. Thus the investigators planned a meta-analysis to compare outcomes of BP-DES versus PP-DES in obstructive co...
Detailed Description
Evidence supporting use of bioabsorbable polymer drug eluting stents (BP-DES) is uncertain. Previous studies suggested that BP-DES are at least as effective as durable polymer drug eluting stents (PP-...
Eligibility Criteria
Inclusion
- randomized studies
- studies reporting clinical outcomes as overall death and/or acute myocardial infarction and/or late stent thrombosis (ARC definition)\[\*\*\] and/or target lesion revascularization and/or late lumen loss
- follow up period longer than 6 months.
Exclusion
- duplicate reporting (in which case the manuscript reporting the largest sample or the longest follow-up was selected)
- inability to compute risk estimates due to absence of clinical event in one of the groups
- studies presenting composite major adverse cardiac event (MACE) and not individual end points.
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
6221 Patients enrolled
Trial Details
Trial ID
NCT01466634
Start Date
August 1 2011
End Date
October 1 2011
Last Update
November 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale Maggiore della Carità
Novara, Italy, 28100